Appendix 4D and Interim Financial Report
Filed with ASX · · 23 pages · English
There were no dividends paid, recommended or declared during the current financial period. Comments The loss for the Group after providing for income tax amounted to $10.743m (31 December 2024: $7.441m). 3. Net tangible assets Current period There were no dividends paid, recommended or declared during the current financial period. There were no dividends paid, recommended or declared during the pr
Earlier from Artrya
- Quarterly Activities/Appendix 4C Cash Flow Report
- Cone Health Becomes Third U.S. Customer
- First Revenues from Salix Coronary Plaque Module
- Second US Commercial Customer - Northeast Georgia
- S&P DJI Announces December 2025 Quarterly Rebalance
Later from Artrya
- S&P DJI Announces March 2026 Quarterly Rebalance
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- March Quarterly Activities Report and Appendix 4C
- Northeast Georgia Health System goes live with Salix
- June Quarterly Activities Report and Appendix 4C
Follow Artrya into a list and get an email when it puts out news.
Follow Artrya